Global Biosurgery Market Research Report: Forecast (2025-2030)

Market Definition

Biosurgery, in simple terms, refers to the process of healing a human's severely infected wounds by using live sterile maggots. The method of Biosurgery is carried out to eliminate the devitalized tissues and prevent the infection from growing. The greenbottle fly larvae are notably considered the best-living organisms to treat human wounds since they are placed on the wounds and consume all the dead and decaying flesh. Ultimately the healthy flesh is left, and as a result, the new tissues on that part grow again.

Market Insights & Analysis: Global Biosurgery Market (2025-30)

The Global Biosurgery Market size was valued at around USD 14.32 billion in 2024 and is projected to reach USD 19.41 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 5.20% during the forecast period, i.e., 2025-30. The primary drivers of growth in this market are the rising prevalence and incidence of diverse disorders, such as obesity and cardiovascular disease. In addition, the market is being boosted by the need to manage blood loss in patients and ongoing research and development efforts to introduce novel products. The other anticipated factors accountable for the expansion of the market include the snowballing demand for biosurgery products, as it helps heal wounds and end the infections caused during old age, fatal accidents, musculoskeletal disorders, and several others.

*Boost strategic growth with in-depth market analysis - Get a free sample preview today!

Moreover, the market is driven by the increasing need for advanced surgical procedures that require highly effective and efficient hemostatic agents, sealants, and adhesives. Additionally, there is an increasing incidence of trauma, accidents, and sports-related injuries that require surgical treatment, further driving the adoption of biosurgery products. Furthermore, several companies are investing in R&D to develop new products that offer better hemostatic properties, faster healing, and reduced scarring. These advancements are attracting a large patient pool, driving the demand for biosurgery products.

Global Biosurgery Market Key Driver:

A High Majority of the Global Population Suffering from Cardiovascular Disease - The exponential increase in the market can be easily witnessed owing to a high proportion of people suffering from cardiovascular disease. For example, the World Health Organization (WHO) reports that over 18 million of the global population die yearly due to cardiovascular diseases, which is undoubtedly a huge number compared to the deaths caused by any other illness. Moreover, old age people constitute the majority of such conditions due to rapid changes in their hearts and blood vessels, promoting the risks of developing a surgical situation. Hence, surgeons are bringing in the use of biosurgery to heal wounds faster, thereby contributing to growth prospects.

Global Biosurgery Market Possible Restraint:

Lack of Awareness Regarding Available Surgical Methods and High Cost Associated - The absence of knowledge about the surgery amongst several individuals and its massive cost is the important factor that unquestionably hampers the growth of the market. First, people around the world still need to be made aware of biosurgery and the various beneficial aspects associated with it. Even in evolving economies, adequate information about the same needs to be improved, so the market may experience a little complication while expanding. Secondly, the high cost of surgery is another reason for the hindrance of the market since before underperforming a surgery, pre and post-surgery costs are generally costly. In addition, the expensive medicines, post-surgery costume, and other surgical tools that are hard to afford act as the primary barrier to surpassing the growth milestone.

Global Biosurgery Market Growth Opportunity:

Rapid Expansion in the Adoption of Advanced Medical Technologies - The rapid expansion in the development of Medical Technologies and surgical tools is directly relatable to the growth of the Global Biosurgery Market. As soon as the medical industry on a global level has begun promoting the use of surgical robots, a large number of surgeries are being conducted with the help of advanced computing technologies and surgical tools, which has entirely left no chance of any error or mishap since the human interaction is getting diminished. Furthermore, the other substantial growth factor is the increasing investment of several countries' governments toward enhancing the healthcare sector's industrial landscape. The Research and Development (R&D) activities are also strengthening, so the market tends to rise exponentially.

Global Biosurgery Market (2025-30): Segmentation Analysis

The Global Biosurgery Market study of MarkNtel Advisors evaluates & highlights the major trends & influencing factors in each segment & includes predictions for the period 2025–2030 at the global, regional, and national levels. Based on the Product Type, and Application the market has been further classified as:

By Product Type

• Anti-Adhesive Agents
• Bone Graft Substitutes
• Hemostatic and Surgical Sealant
• Mesh

Out of all the product types, Hemostatic and Surgical Sealants have the potential to expand the market's current scenario with the largest market share. Since these products are widely used during surgeries to prevent the human body from excessive blood loss and to seal tissues to eliminate the risk of fluid and air leakage, doctors are leaning towards these products for carrying out surgeries. Hence, a surge in demand for Hemostatic and Surgical Sealant products is expected to bode well for the expansion of the Global Biosurgery Market during the estimated period.

• In March 20xx, Ax-Surgi Surgical Hemostat received 510(k) clearance from the US Food and Drug Administration (FDA), according to Advamedica Inc., a biomaterial-focused medical technology startup. As a result, the only chitosan-based hemostat approved for reducing severe surgical bleeding is Ax-Surgi. Ax-Surgi is built on a cutting-edge biopolymer platform that reduces bleeding by acting bioadhesive. For patients exhibiting Class III or Class IV bleeding, it is approved for the momentary control of internal organ space bleeding. Additionally, it can be applied to stop extreme bleeding from surgical wounds and traumatic injuries.

By Application

• Cardiovascular and Thoracic Surgery
• Neuro and Spine Surgery
• Orthopedic Surgery
• General Surgery

Cardiovascular and Thoracic Surgery are significant contributors to market expansion. It is primarily due to the high percentage of people suffering from cardiovascular and thoracic illness, leading to the market's exponential growth. Furthermore, the bulk of these disorders mainly affects older individuals because their blood arteries and hearts change quickly in old age, increasing the likelihood that they may need surgery. In order to treat such conditions, a patient must undergo surgery; as a result, doctors are heavily relying on biosurgery and products associated with it to treat the patient, thus, aiding in the proliferation of the market.

Global Biosurgery Market Regional Projection

Geographically, the Global Market expands across:

• North America
• South America
• Europe
• Middle East & Africa
• Asia-Pacific

Of these, the North American region was previously accountable for preserving its supremacy in the Global Biosurgery Market during the historical period. The same trend can be expected since the foresaid region is more likely to lead the market with a substantial share. As the high proportion of people having the symptoms of chronic disease belong to the North American region, the growth of the market can be already witnessed due to the fact that it will promote the surgeries which will ultimately trigger the dominant players of the industry to increase their production according to the expanding demands of the surgical products and other related equipment. In addition to this, the Asia-Pacific region is just a little behind, acting as the second-highest contributor in the expansion of the market owing to an increase in the old-age population, a rise in sport-related surgery and injury, and the rising demands for biosurgery products as well.

Global Biosurgery Market Industry Recent Development:

• In 2024: Baxter International launched the Hemopatch Sealing Hemostat with room temperature storage, a ready-to-use absorbable collagen pad designed for tissue sealing, dura sealing, and hemostasis. This product evolution, now available across Europe, directly addresses surgeon needs for rapid and sustained hemostasis in both open and minimally invasive surgeries.
• In 2024: Johnson & Johnson secured FDA approval for a next-generation surgical sealant specifically indicated for minimally invasive procedures. This new sealant offers enhanced tissue adhesion and a reduced risk of leakage, supporting improved surgical outcomes and patient safety.
• In 2024: Medtronic declared a partnership with a leading research institution to develop novel biosurgery solutions using advanced biomaterials. This collaboration aims to address unmet needs in surgical hemostasis and tissue repair.

Gain a Competitive Edge with Our Global Biosurgery Market Report

1. Global Biosurgery Market Report by MarkNtel Advisors provides a detailed & thorough analysis of market size, growth rate, competitive landscape, and key players. This comprehensive analysis helps business organizations to gain a holistic understanding of market dynamics & make informed decisions.
2. This report also highlights current market trends & future projections, allowing business organizations to identify emerging opportunities & potential challenges. By understanding market forecasts, companies can align their strategies & stay ahead of the competition.
3. Global Biosurgery Market Report aids in assessing & mitigating risks associated with entering or operating in the market. By understanding market dynamics, regulatory frameworks, and potential challenges, business organizations can develop strategies to minimize risks & optimize their operations.

*Reports Delivery Format - Market research studies from MarkNtel Advisors are offered in PDF, Excel and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address.